Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cablivi
Pharma
Sanofi eyes successors for CEO Olivier Brandicourt
Sanofi is working on a succession plan for CEO Olivier Brandicourt, who'll hit mandatory retirement age in 2021.
Eric Sagonowsky
Mar 18, 2019 2:51pm
Buoyed by Dupixent, Sanofi expects a brighter 2019
Feb 7, 2019 12:22pm
Cablivi is Sanofi’s first approval from Ablynx buyout
Feb 6, 2019 12:23pm
Dupixent and vaccines bring Sanofi back to growth
Oct 31, 2018 12:33pm
Sanofi’s first Ablynx drug Cablivi wins EU approval
Sep 4, 2018 11:08am
Sanofi’s first product from the Ablynx deal wins CHMP backing
Jun 29, 2018 10:16am
